Floatz logo

Metformin

Viral Infection

Oxford University Clinical Research Unit, VietnamSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Viral Infection cohort.

Asset / SponsorPhaseRating
Quadrivalent Inactivated Influenza Vaccine
University of Pennsylvania
Phase 4BB
HEPATITIS C IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
Biotest Pharmaceuticals Corporation
Phase 3BB
Primepro™/ Primemsk™
Thomas Advanced Medical LLC
Phase 1/2CCC
G 207
M.D. Anderson Cancer Center
Phase 1CC
Sodium Chloride
University of Edinburgh
N/AD

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →